First Manhattan’s Albany Molecular Research Inc AMRI Stock Holding History

First Manhattan’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,000	Closed	-$59K	–	1489
2015 Q4	$59K	Hold	3,000	–	–	﹤0.01%	918
2015 Q3	$52K	Hold	3,000	–	–	﹤0.01%	931
2015 Q2	$60K	Hold	3,000	–	–	﹤0.01%	930
2015 Q1	$52K	Hold	3,000	–	–	﹤0.01%	962
2014 Q4	$48K	Hold	3,000	–	–	﹤0.01%	992
2014 Q3	$66K	Hold	3,000	–	–	﹤0.01%	905
2014 Q2	$60K	Hold	3,000	–	–	﹤0.01%	913
2014 Q1	$55K	Hold	3,000	–	–	﹤0.01%	935
2013 Q4	$30K	Hold	3,000	–	–	﹤0.01%	1023
2013 Q3	$38K	Hold	3,000	–	–	﹤0.01%	983
2013 Q2	$37K	Buy	+3,000	New	+$32.5K	﹤0.01%	983

Other funds holding AMRI

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

OWP

Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

ACM

American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return

PIP

Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Manhattan's AMRI Position: Q1 2016 in Review

First Manhattan sold out of Albany Molecular Research Inc (AMRI) in Q1 2016, closing a stake of 3,000 shares — an estimated $59K sold.

First Manhattan first reported a position in AMRI in Q2 2013 and held it in 11 quarters. The position peaked at $66K in Q3 2014. 141 funds tracked by Wall St. Rank hold AMRI as of Q1 2016.

First Manhattan reported no remaining Albany Molecular Research Inc position as of Q1 2016 after selling out during the quarter.
First Manhattan sold 3,000 Albany Molecular Research Inc shares in Q1 2016, an estimated $59K.
First Manhattan first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 11 quarters.
First Manhattan's Albany Molecular Research Inc position peaked at $66K in Q3 2014.
141 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2016.

Based on First Manhattan's 13F filing for Q1 2016, filed 22 Apr 2016.